COMP <GO>
EOLS vs PHAT // EV/EBITDA & P/E VALUATION
Evolus Inc. (NASDAQ) VS. Phathom Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: EOLS 3
— PHAT 3
■ METRIC PARITY
LAST: $7.16 (-2.58%) • MKT CAP: $485.5M
valuation
—
LAST: $5.92 (+3.05%) • MKT CAP: $466.6M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EOLS VS. PHAT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EOLS | PHAT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.30% | 87.10% | -20.80 | PHAT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.20% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -11.00% | -60.00% | +49.00 | EOLS | /operating-margins <GO> |
| Net Profit Margin | -17.40% | -0.10% | -17.30 | PHAT | /net-margins <GO> |
| Revenue Growth (YoY) | 11.60% | 180.00% | -168.40 | PHAT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 36.7 | +9.70 | EOLS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $485.5M | $466.6M | $18.9M | EOLS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EOLS REV | PHAT REV | EOLS GROSS % | PHAT GROSS % | EOLS FCF | PHAT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $297.2M | $175.1M | 66.3% | 87.1% | -$45.7M | -$167.0M |
| FY 2024 | $266.3M | $55.3M | 68.5% | 85.6% | -$19.5M | -$266.9M |
| FY 2023 | $202.1M | $682.0K | — | — | -$34.0M | -$137.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EOLS // BETA —
PHAT // BETA —